C
ARQT icon

Covestor’s Arcutis Biotherapeutics ARQT Stock Holding History

Covestor’s Portfolio ARQT Stock Details ARQT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$0 Sell
8
-1
-11% -$26 ﹤0.01% 2240
2025
Q4 		$0 Hold
9
– – ﹤0.01% 2248
2025
Q3 		$0 Hold
9
– – ﹤0.01% 2265
2025
Q2 		$0 Sell
9
-1
-10% -$14 ﹤0.01% 2188
2025
Q1 		$0 Hold
10
– – ﹤0.01% 2191
2024
Q4 		$0 Buy
10
+1
+11% +$11 ﹤0.01% 2209
2024
Q3 		$0 Sell
9
-1
-10% -$10 ﹤0.01% 2187
2024
Q2 		$0 Hold
10
– – ﹤0.01% 2221
2024
Q1 		$0 Sell
10
-8
-44% -$60 ﹤0.01% 2216
2023
Q4 		$0 Buy
18
+11
+157% +$30 ﹤0.01% 2123
2023
Q3 		$0 Sell
7
-1
-13% -$9 ﹤0.01% 2092
2023
Q2 		$0 Hold
8
– – ﹤0.01% 2107
2023
Q1 		$0 Hold
8
– – ﹤0.01% 1991
2022
Q4 		$0 Sell
8
-1
-11% -$17 ﹤0.01% 2035
2022
Q3 		$0 Sell
9
-1
-10% -$23 ﹤0.01% 1955
2022
Q2 		$0 Buy
+10
New +$205 ﹤0.01% 1882
2022
Q1 		– Sell
-16
Closed – – 2085
2021
Q4 		$0 Buy
+16
New +$318 ﹤0.01% 2101

Other funds holding ARQT

SCM
Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $22.9B AUM 115.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return